Skip to main content

Table 1 Excluded medicinal products

From: Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissions

 

Excluded

Included

Topical anesthetics

Lidocaine 2.5%, prilocaine 2.5% cream (EMLA®) or tetracaine 4% gel (Ametop®)

LAT gel (lidocaine 4% and adrenaline 0.1% and tetracaine 0.5% gel)

Ranitidine

Ranitidine added to TPN

Ranitidine administered otherwise

Heparin

Heparin administered as intermittent intravenous heparin flush.

Intermittent intravenous injection other than heparin flush, heparin administered as continuous intravenous infusion or as subcutaneous injection.

Total parenteral nutrition (TPN)

Total parenteral nutrition (TPN)

 

Intravenous hydration fluids

Intravenous hydration fluids

Any drugs added to intravenous fluids

Rectal washouts

Rectal washouts with sodium chloride 0.9%

 

Blood products

Red cells

Antithrombin III concentrate

Platelets

Dried prothrombin complex

Cryoprecipitate

Drotrecogin alfa (activated)

Albumin solutions

Factor VIIa (recombinant)

Fresh frozen plasma

Factor VIII fraction, dried

Factor VIII inhibitor by-passing fraction

Factor IX fraction, dried

Factor XIII fraction, dried

Protein C concentrate

Oxygen therapy

Oxygen therapy